Form4.ai tracks every SEC insider trade in real time. See every DNLI insider filing with a free account — no card.
See every DNLI insider filing — free account, no card.
Free accountDenali Therapeutics Inc. (DNLI) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $370K. Most recent filing: Sept. 9, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 9, 2026 SEC filing | Chin Peter Scott Chief Medical Officer | Sold | $36,868 | — |
| Sep 4, 2026 SEC filing | Thornberry Nancy Director | Sold | $261,929 | — |
| Aug 14, 2026 SEC filing | Watts Ryan J. President and CEO | Gift | — | — |
Create a free account to see all 4 DNLI filings from the last 90 days. No card needed.
Create free accountWant DNLI insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.